Navigation Links
Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
Date:11/5/2008

on expense of $6.9 million in the first nine months of 2008 compared with $4.5 million for the same period in 2007, and $3.6 million of depreciation and amortization expenses, compared with $2.9 million in the same period in 2007.

Recent Highlights and Accomplishments

Commercial Progress

-- More than 10,220 test results delivered in the third quarter of 2008,

compared with more than 5,950 test results delivered in the third

quarter of 2007, an increase of 72 percent year-over-year.

-- More than 75,000 Oncotype DX test results have been delivered to

patients.

-- Gained coverage for an additional 7.9 million lives for reimbursement

of Oncotype DX through contracts, policies and agreements, bringing the

total U.S. covered lives to approximately 89 percent of insured lives

including: Coventry Health Care (4.4 million lives), Blue Cross and

Blue Shield of Massachusetts (1.3 million lives), Medica Health Plans,

HMSA Blue Cross Blue Shield of Hawaii, and WPS Health Insurance in

Wisconsin.

-- Named a Vice President to oversee European markets.

-- Established distribution agreements in Australia and Taiwan.

-- Received test samples from 39 countries to date.

-- Oncotype DX included in the updated 2008 guidelines of the Dutch

Institute for Healthcare Improvement.

Product Pipeline

-- Enhanced clinical utility of Oncotype DX reports by including

quantitative HER2 scores; quantitative estrogen receptor and

progesterone receptor scores were added earlier this year.

-- Completed European study using Oncotype DX in node-negative and

node-positive, breast cancer patients treated with aromatase

inhibitors, which was accepted for oral presentation at the San Antonio

Breast Cancer Symposium in December 2008.

-- Continued to make progress toward a clinical validation
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
3. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
4. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
8. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... BOSTON and TEL AVIV, Israel ... ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in ... , the Company,s President and Chief Executive Officer, and ... will participate in the Benchmark Company, LLC One-on-One Investor Conference ... East Wisconsin Ave., Milwaukee, WI. ...
(Date:5/24/2013)... 24, 2013 Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... , Ph.D., the Company,s Vice President, Biology and ... & Corporate Communications, will present an overview of Senomyx,s ... a.m. Eastern Time (7:25 a.m. Pacific Time) during the ...
(Date:5/24/2013)... Texas (PRWEB) May 24, 2013 ... benchmarking survey on kinase profiling carried out in ... details of the breakdown of the responses for ... the future (2015). It also highlights some interesting ... survey groupings. Two bottom-up models were developed to ...
(Date:5/24/2013)... Toronto, Canada (PRWEB) May 24, 2013 ... selective barriers, and uptake or efflux transporters at the ... may be related to unbound fractions in the tissue ... understanding of these disposition challenges is required to guide ... and to identify any species-dependent variables that may impact ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2
... Inc. (NYSE: AOB ), a leading manufacturer and ... that it plans to release third quarter 2007 financial ... The company will hold a conference call on ... fiscal third quarter results. Listeners may access the,call by ...
... Kosan Biosciences,Inc. (Nasdaq: KOSN ) today ... Day on Wednesday, October 31, 2007, beginning at ... In addition to,presentations by Kosan,s Executives, Robert G. ... and Pieter Timmermans, Ph.D., Senior,Vice President, Drug Discovery ...
... Oct. 24 Codexis, Inc., a private,biotechnology company ... the opening of Codexis Laboratories Singapore,Pte. Ltd. (CLS). ... Asia, and,is an expansion of the company,s research ... will support the company,s pharmaceuticals business in,both the ...
Cached Biology Technology:American Oriental Bioengineering Announces Reporting Date for Third Quarter 2007 Financial Results 2Kosan Biosciences to Host Research & Development Day on October 31, 2007 2Kosan Biosciences to Host Research & Development Day on October 31, 2007 3Codexis Opens Singapore Laboratory 2
(Date:5/23/2013)... HOUSTON (May 23, 2013) A new report ... responsible for helping pupils engage in at least 60 ... school day. , No more than half of American ... hour of vigorous or moderate intensity physical activity daily, ... , "Because children are in school for nearly half ...
(Date:5/23/2013)... team reveal the interplay of brain chemicals which help ... Trust and BBSRC. , By changing the way ... abilities. While these changes can affect the strength of ... of that response. , Lead author Alex ... with others, you can make yourself better heard by ...
(Date:5/22/2013)... in fuel cell powered buses, including a team ... electrode degradation processes and bus membrane durability. , ... degradation stressors in the operating cycle of the ... of the study, led by SFU graduate student ... study at Burnaby-based Ballard Power Systems and funded ...
Breaking Biology News(10 mins):Schools should provide students with daily physical activity, IOM recommends 2Tests lead to doubling of fuel cell life 2
... written by Rosa Binimelis, Walter Pengue and Iliana Monterroso, ... University of Barcelona, University of Buenos Aires and the ... The article describes the geographical advance of the invasion ... the invasion process to discuss the major drivers and ...
... Supply Chain Council (SCC) announced today it has joined ... offer a unique new program that will enhance the ... professionals.SCC is the world,s leading authority on supply chain ... while APICS is the leader in operations management and ...
... ALEXANDRIA, Va., May 7 Today, the White House ... funding for the Carl D. Perkins Career and Technical ... Act is the primary source of federal funding that ... careers. The Association for Career and Technical Education (ACTE) ...
Cached Biology News:Weed resistance to glyphosate in genetically modified soybean cultivation in Argentina 2Supply Chain Council Partners With APICS The Association for Operations Management 2Obama Budget Level Funds Career Technical Education 2Obama Budget Level Funds Career Technical Education 3
Anti-human C5a/C5a des-Arg (neo-epitode), Clone 2952, Monoclonal Antibody...
Reacts with the 80 kDa fragment of the M-chain of human merosin....
ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...
... Rabbit polyclonal to ZFP91 ( ... Antigen: Synthetic ... 280 of human ZFP91. (Note: ... Entrez ...
Biology Products: